Head-to-head · Value Score
bmiMD vs Lean Rx
Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, Lean Rx a 64. Here's who gives you the honest lower price — and where each one bites back.
bmiMD
#11 · Grade A · Great Deal
Est. first month
$99/mo
Save ~93% vs brand-nameLean Rx
#324 · Grade C · Watch List
Est. first month
From $266/mo (starting dose, compounded)
Save ~80% vs brand-nameThe verdict
bmiMD takes it on Value Score, 89 to 64 — an est. $99/mo first month, with no teaser step-up baked in. Lean Rx isn't out of it: Patients wanting compounded GLP-1 in injectable, sublingual, or tablet form.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | bmiMD | Lean Rx |
|---|---|---|
| Value Score | 89 (A) | 64 (C) |
| Est. first month | $99/mo | From $266/mo (starting dose, compounded) |
| Save vs brand-name | ~93% | ~80% |
| Semaglutide | $99/mo | From $266/mo (starting dose, compounded) |
| Tirzepatide | $139/mo | From $399/mo (starting dose, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
bmiMD
Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.
Why it's a deal
- $99 flat semaglutide and a low $139 tirzepatide
- Available in all 50 states
- Both molecules priced up front
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Thin public track record; no oral or brand-name option
Lean Rx
Lean Rx is a Sacramento-based telehealth technology platform offering compounded GLP-1 weight loss medications.
Why it's a deal
- Both semaglutide and tirzepatide offered
- Three formulations: injectable, sublingual, and tablet
- Upfront pricing with no hidden fees advertised
- Semaglutide starts at a low $266/month
- Telehealth call with a licensed provider before prescribing
The fine print
- Compounded-only; no FDA-approved branded options
- No published state availability list
- Platform is technology only, not a healthcare provider itself
- Provider credentials not detailed on site
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores bmiMD is ranked on the bmiMD alternatives board, and the same list for the other side is on alternatives to Lean Rx.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.